UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO

Endowment

Position in ABBV — AbbVie Inc.

CIK 1019231 AUSTIN, TX

Back to ABBV Full portfolio

Position in ABBV

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$302,974

+$266,416 QoQ

Shares Held

1,204

+652.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#3,621

of 4,153 holders

Holding Since

Dec 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO holds $7,291,310 across 9 Drug Manufacturers - General names. ABBV ranks #5 (4.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PFE	Pfizer Inc	165,020	$3,973,681
2	LLY	ELI LILLY & Co	1,114	$1,336,165
3	NVS	Novartis AG	4,919	$770,905
4	JNJ	Johnson & Johnson	1,678	$426,161
5	ABBV	AbbVie Inc. This page	1,204	$302,974
6	MRK	Merck & Co., Inc.	1,783	$229,115
7	GILD	Gilead Sciences, Inc.	950	$120,023
8	BMY	Bristol Myers Squibb Co	1,460	$84,125

All Filings in ABBV

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$302,974	1,204	+652.5%	Shares	Sole	2026-08-03
2025-12-31	$36,558	160	+1233.3%	Shares	Sole	2026-02-17
2025-03-31	$2,514	12	-98.3%	Shares	Sole	2025-05-07
2024-12-31	$126,877	714	0.0%	Shares	Sole	2025-02-19
2024-09-30	$141,000	714	0.0%	Shares	Sole	2024-11-13
2024-06-30	$122,465	714	-25.9%	Shares	Sole	2024-09-17
2024-03-31	$175,544	964	+35.0%	Shares	Sole	2024-08-29
2023-12-31	$110,648	714	0.0%	Shares	Sole	2024-08-29
2023-09-30	$106,428	714	-52.4%	Shares	Sole	2024-08-29
2022-12-31	$242,415	1,500	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.